CHICAGO, Ill. (WPVI) -- A new drug to treat C. Difficile, also known as C. Diff, is getting C. diff is a common bacterial infection of the gut, and it can be deadly. In two Phase 3 clinical trials, an ...

Most laboratories have begun using polymerase chain reaction assays, or the PCR technique, as opposed to enzyme-linked immunosorbent assay detection, also known as ELISA testing, to diagnose ...

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

A single Clostridium difficile infection presents an array of challenges for hospitals. A December 2015 study in the American Journal of Infection Control found C. difficile infections can increase ...

Please provide your email address to receive an email when new articles are posted on . Lewis and colleagues tested the three EHR-based interventions at three hospitals. The first intervention, ...

SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...

Please provide your email address to receive an email when new articles are posted on . Two-step testing was associated with a decrease in hospital-onset C. difficile infection. Similar decreases were ...

Dogs have previously shown promise in sniffing out bacterial infections, but a new Canadian study is walking those assertions back. Investigators with the Michael Garron Hospital were recently the ...

Testing for Clostridium difficile infection is significantly lower than expected during diagnosis of inflammatory bowel disease, according to a study in Inflammatory Bowel Diseases, the official ...

Great Basin Corp. has announced it has received FDA 510(k) clearance for its molecular diagnostic test for Clostridium difficile, according to a news release (pdf). “Workflow matters, especially when ...

CINCINNATI, Ohio — Meridian Bioscience Inc. reported record revenue and net income for its fiscal first quarter, despite increased competition for sales of C. difficile test kits. The Cincinnati ...